Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia

[Figure: see text]

Detalles Bibliográficos
Autores principales: Varona, Jose F, Núñez, Elena, Fernández Félix, Borja M., Castellano Vázquez, Jose María, Cubillo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007736/
https://www.ncbi.nlm.nih.gov/pubmed/35094895
http://dx.doi.org/10.1016/j.ejim.2022.01.031
_version_ 1784905595540733952
author Varona, Jose F
Núñez, Elena
Fernández Félix, Borja M.
Castellano Vázquez, Jose María
Cubillo, Antonio
author_facet Varona, Jose F
Núñez, Elena
Fernández Félix, Borja M.
Castellano Vázquez, Jose María
Cubillo, Antonio
author_sort Varona, Jose F
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-10007736
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Federation of Internal Medicine. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-100077362023-03-13 Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia Varona, Jose F Núñez, Elena Fernández Félix, Borja M. Castellano Vázquez, Jose María Cubillo, Antonio Eur J Intern Med Letter to the Editor [Figure: see text] European Federation of Internal Medicine. Published by Elsevier B.V. 2022-05 2022-01-21 /pmc/articles/PMC10007736/ /pubmed/35094895 http://dx.doi.org/10.1016/j.ejim.2022.01.031 Text en © 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Varona, Jose F
Núñez, Elena
Fernández Félix, Borja M.
Castellano Vázquez, Jose María
Cubillo, Antonio
Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia
title Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia
title_full Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia
title_fullStr Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia
title_full_unstemmed Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia
title_short Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia
title_sort efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with covid-19 pneumonia
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007736/
https://www.ncbi.nlm.nih.gov/pubmed/35094895
http://dx.doi.org/10.1016/j.ejim.2022.01.031
work_keys_str_mv AT varonajosef efficacyandsafetyoftherapeuticvsprophylacticbemiparininnoncriticallyillpatientswithcovid19pneumonia
AT nunezelena efficacyandsafetyoftherapeuticvsprophylacticbemiparininnoncriticallyillpatientswithcovid19pneumonia
AT fernandezfelixborjam efficacyandsafetyoftherapeuticvsprophylacticbemiparininnoncriticallyillpatientswithcovid19pneumonia
AT castellanovazquezjosemaria efficacyandsafetyoftherapeuticvsprophylacticbemiparininnoncriticallyillpatientswithcovid19pneumonia
AT cubilloantonio efficacyandsafetyoftherapeuticvsprophylacticbemiparininnoncriticallyillpatientswithcovid19pneumonia

Ejemplares similares